Children's Hospital Boston launches science and clinical innovation blog

Children's Hospital Boston launches science and clinical innovation blog  

Contact:
Bess Andrews, Public Affairs
Children's Hospital Boston
[email protected]
617-816-2350 

 
Vector, Children's Hospital Boston's new blog, goes public today, covering hot and timely topics in biomedicine with a special interest in the scientific, business and policy issues affecting the translation of discovery to patient care. The blog is written by and for scientists, clinicians, inventors, innovators and followers of the latest discoveries, topics and trends in science and medicine.  Contributors are from within Children's and from outside stakeholders.
 
Replacing Children's print magazine of the same name that covered similar topics in greater depth, Vector blog is a timely, quick read designed to bring readers up to date on the latest news from Children's and beyond. It will also cover issues related to biomedical ethics, research funding and other topics critical to the success of research advances.
 
Check out embryonic stem cell researcher Dr. George Daley's post on pluripotent stem cells as a platform for drug discovery, neurosurgeon Dr. Joseph Madsen's post on "bridge building" as a means to advance  translation in medicine, patent attorney David Resnick's controversial post on patenting genes, and psychologist-inventor Dr. Eugene Goldfield on how he developed the idea for "smart clothing" to help babies with cerebral palsy.  Also find a link to a roundtable dicussion in Nature with Children's attorney and ethicist Patrick Taylor on the recent flip- flop on the use of NIH funds for stem cell research and more.
 
 Read Vector blog (http://vectorblog.org/), join the Vector Facebook page (http://www.facebook.com/science4care) and sign up for the Vector Twitter feed http://twitter.com/science4care.
 
Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including nine members of the National Academy of Sciences, 12 members of the Institute of Medicine and 13 members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 396-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital and its research visit: www.childrenshospital.org/newsroom.
 
 

Suggested Articles

Barely two years after paying up $263 million for the ex-Asia rights to BeiGene’s tislelizumab, Celgene is bowing out—to the tune of $150 million.

A University of Pennsylvania team discovered that a protein called TOX helps determine the fate of exhausted T cells in cancer and other diseases.

AstraZeneca is set to spend $630 million on R&D in South Korea over the next five years as part of a wider cooperative agreement.